Formoterol in Diabetes (NCT07022418)
Prospective Randomized Pilot Trial of Formoterol in Patients With Diabetic Kidney Disease
๐ฉบ Plain-English Summary (8th-Grade Level)
The purpose of the study is to evaluate if formoterol fumarate is effective in treating patients with diabetic kidney disease. Study participants will be randomly assigned to either receive formoterol fumarate (in addition to their current standard of care treatment) or standard of care treatment only. Study participants will have a 50% chance of receiving formoterol fumarate and a 50% chance of not receiving formoterol fumarate. Both groups will continue their standard of care treatment during the study. The primary goal is to gather data on feasibility and effect sizes to properly power a future clinical trial.
Who can join: Review the eligibility criteria below.
Location: Medical University of South Carolina โ Charleston, South Carolina
Age range: 18 Years to 75 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Medical University of South Carolina โ Charleston, South Carolina
๐ Contact the Study Coordinator
Phone: (843) 792-0965
Email: recruitment@musc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetic Nephropathies
- A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes โ Boston, Massachusetts
- Study of WAL0921 in Patients With Glomerular Kidney Diseases โ Los Angeles, California
- Transformative Research in Diabetic Nephropathy โ Little Rock, Arkansas
- Transformative Research in Diabetic Nephropathy 2.0 โ Philadelphia, Pennsylvania
- Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease โ Stanford, California
Explore by condition: All Diabetic Nephropathies clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.